Filters

Joe Zein, Benjamin Gaston, Peter Bazeley, Mark D DeBoer, Robert P Igo, Eugene R Bleecker, Deborah Meyers, Suzy Comhair, Nadzeya V Marozkina, Calvin Cotton, Mona Patel, Mohammad Alyamani, Weiling Xu, William W Busse, William J Calhoun, Victor Ortega, Gregory A Hawkins, Mario Castro, Kian Fan Chung, John V Fahy, Anne M Fitzpatrick, Elliot Israel, Nizar N Jarjour, Bruce Levy, David T Mauger, Wendy C Moore, Patricia Noel, Stephen P Peters, W Gerald Teague, Sally E Wenzel, Serpil C Erzurum, Nima Sharifi

Proceedings of the National Academy of Sciences of the United States of America 2020;117(4):2187-2193

Full Text

Abstract

HSD3B1 status as a biomarker of androgen deprivation resistance and implications for prostate cancer.

Daniel Hettel, Nima Sharifi

Nature reviews. Urology 2019;15(3):191-196

Full Text

Abstract

HSD3B1 genotype and outcomes in metastatic hormone-sensitive prostate cancer with androgen deprivation therapy and enzalutamide: ARCHES.

Arun A Azad, Fabian Zohren, Gabriel P Haas, Jason W D Hearn, Mona Patel, Andrew J Armstrong, Jennifer Sugg, Arnulf Stenzl, Nima Sharifi, Michele Wozniak

Cell reports. Medicine 2024;5(8):101644

Free Full Text

Abstract

HSD3B1 Genotype and Clinical Outcomes in Metastatic Castration-Sensitive Prostate Cancer.

Jason W D Hearn, Christopher J Sweeney, Nima Almassi, Chad A Reichard, Chandana A Reddy, Hong Li, Brian Hobbs, David F Jarrard, Yu-Hui Chen, Robert Dreicer, Jorge A Garcia, Michael A Carducci, Robert S DiPaola, Nima Sharifi

JAMA oncology 2020;6(4):e196496

Free Full Text

Abstract

Germline variants and response to systemic therapy in advanced prostate cancer.

Eric Johnson, Roberto Nussenzveig, Neeraj Agarwal, Umang Swami

Pharmacogenomics 2020;21(1):75-81

Full Text

Abstract

Multiple signal transduction pathways mediate interleukin-4-induced 3beta-hydroxysteroid dehydrogenase/Delta5-Delta4 isomerase in normal and tumoral target tissues.

S Gingras, S Côté, J Simard

The Journal of steroid biochemistry and molecular biology 2001;76(1-5):213-25

Full Text

Abstract

Expression and gene variation studies deny association of human HSD3B1 gene with aldosterone production or blood pressure.

Germaine C Verwoert, Johannes Hofland, Najaf Amin, Francesco U S Mattace-Raso, Eric J G Sijbrands, Albert Hofman, Anton H van den Meiracker, André G Uitterlinden, Cornelia M van Duijn, Frank H de Jong, A H Jan Danser

American journal of hypertension 2015;28(1):113-20

Full Text

Abstract

Hypocretin/orexin increases the expression of steroidogenic enzymes in human adrenocortical NCI H295R cells.

Jan Wenzel, Nicole Grabinski, Cordula A Knopp, Andreas Dendorfer, Manjunath Ramanjaneya, Harpal S Randeva, Monika Ehrhart-Bornstein, Peter Dominiak, Olaf Jöhren

American journal of physiology. Regulatory, integrative and comparative physiology 2009;297(5):R1601-9

Free Full Text

Abstract

Results: 1 – 15 / 17

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Progesterone Reductase""[mesh_terms]

Mutation of HSD3B2 Gene and Fate of Dehydroepiandrosterone.

Human placental 3β-hydroxysteroid dehydrogenase/steroid Δ5,4-isomerase 1: Identity, regulation and environmental inhibitors.

Germline HSD3B1 Genetics and Prostate Cancer Outcomes.

HSD3B1, prostate cancer mortality and modifiable outcomes.

Steroidogenic isoenzymes in human hair and their potential role in androgenetic alopecia.

HSD3B1 Genotypes Conferring Adrenal-Restrictive and Adrenal-Permissive Phenotypes in Prostate Cancer and Beyond.

HSD3B1 variant and androgen-deprivation therapy outcome in prostate cancer.

HSD3B1 genotype identifies glucocorticoid responsiveness in severe asthma.

HSD3B1 status as a biomarker of androgen deprivation resistance and implications for prostate cancer.

HSD3B1 genotype and outcomes in metastatic hormone-sensitive prostate cancer with androgen deprivation therapy and enzalutamide: ARCHES.

HSD3B1 Genotype and Clinical Outcomes in Metastatic Castration-Sensitive Prostate Cancer.

Germline variants and response to systemic therapy in advanced prostate cancer.

Multiple signal transduction pathways mediate interleukin-4-induced 3beta-hydroxysteroid dehydrogenase/Delta5-Delta4 isomerase in normal and tumoral target tissues.

Expression and gene variation studies deny association of human HSD3B1 gene with aldosterone production or blood pressure.

Hypocretin/orexin increases the expression of steroidogenic enzymes in human adrenocortical NCI H295R cells.

Results for
""Progesterone Reductase""[mesh_terms]